June 2016

Important New Products

• Akynzeo (netupitant/palonosetron (as hydrochloride)) contains a selective high affinity ...(more)

• Cotellic (cobimetinib fumarate) is an orally available inhibitor of MEK1 and MEK2 ...(more)

• Esbriet (pirfenidone) does not have its mechanism of action fully established as yet. ...(more)

• Jetrea (ocriplasmin (ryp)) is a recombinant truncated form of human plasmin produced by ...(more)

• Orkambi (lumacaftor, ivacaftor) contains lumacaftor which is a CFTR corrector that acts ...(more)

• Palexia IR (tapentadol (as hydrochloride)) is a centrally acting synthetic analgesic combining ...(more)

• Uptravi (selexipag) is an oral, selective, IP prostacyclin receptor agonist, and is structurally ...(more)

 

 

Safety Related Changes

• Betmiga (mirabegron) is now contraindicated in patients with severe uncontrolled ...(more)

Deleted Products

• Dermadrate Cracked Heel Treatment
• Micronor
• Movectro
• Retin A

To contact MIMS editorial please email editorial@mims.com.au. To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email subscriptions@mims.com.au. For more information about MIMS, please see www.mims.com.au

 
Copyright © 2016 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629